NovoCure Limited
NVCR
|
|
| |
|
| Trading Volume | 30,239 |
|
|
23.95 - 11.13 |
| Market Cap Full | $ 2.1B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.1% | 4.6% | -18% | 10.4% |
| Q2 | - | 13.7% | -31% | -16.1% |
| Q3 | - | -13.4% | -61.1% | 9.3% |
| Q4 | - | 4.2% | -4.2% | -3.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -6.8 | 10 | 2 | -22.6 | 82 | -20 | 29.4 | -13.4 | - | - | - | - |
| 2023 | |||||||||||
| 24.3 | -15.6 | -21.9 | 9.6 | 9 | -42.2 | -21.4 | -32.4 | -26.8 | -17.7 | -7.7 | 21.7 |
| 2022 | |||||||||||
| -8.6 | 19.2 | 1.2 | -7.6 | 5 | -13.5 | -2.2 | 20.8 | -7.5 | -7 | 8.8 | -4.5 |
| 2021 | |||||||||||
| -7.8 | -7.4 | -11.4 | 54.4 | -0.1 | 8.7 | -30.6 | -12.9 | -14.1 | -9.9 | -9.8 | -19.8 |
| 2020 | |||||||||||
| -3.9 | -10.6 | -6.9 | -2.3 | 2.5 | -12.1 | 27.8 | 9.5 | 34.2 | 8.9 | 0.8 | 42.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.5 | -0 | -0 | 0 |
| Q2 | -0.5 | -0.2 | -0.1 | 0 |
| Q3 | -0.5 | -0.3 | -0.1 | 0.1 |
| Q4 | 0 | -0.4 | -0.3 | 0.1 |
| A | -1.5 | -0.9 | -0.6 | 0.2 |